In:
Obstetrical & Gynecological Survey, Ovid Technologies (Wolters Kluwer Health), Vol. 74, No. 1 ( 2019-1), p. 10-11
Abstract:
(Abstracted from N Engl J Med 2018;379:731–742) The use of tranexamic acid (TXA) reduces mortality in the setting of postpartum hemorrhage (PPH). This study investigated whether the prophylactic administration of TXA in addition to prophylactic oxytocin in women with vaginal delivery would decrease the incidence of PPH.
Type of Medium:
Online Resource
ISSN:
1533-9866
,
0029-7828
DOI:
10.1097/OGX.0000000000000637
Language:
English
Publisher:
Ovid Technologies (Wolters Kluwer Health)
Publication Date:
2019
detail.hit.zdb_id:
2043471-6